Skip to main content
Fig. 2 | Stem Cell Research & Therapy

Fig. 2

From: A facile and scalable in production non-viral gene engineered mesenchymal stem cells for effective suppression of temozolomide-resistant (TMZR) glioblastoma growth

Fig. 2

5FU sensitivity of various GBM cell lines. Quadruplicates of a U-251MG, b U-87MG and c patient-derived GBM cell lines (2500 cells) were plated. One day later, culture media were replaced with DMEM supplemented with 2% FBS and 5FU (0–100 μg/mL). Cell viability was determined using MTS assay 5 days later. The percentage of cell viability was calculated with no treatment controls set at 100%. Significant differences in 5FU sensitivities between U3008MG/U-251MG/U-87MG and other cell lines were calculated using two-tailed Student’s t test. **P < 0.005

Back to article page